Barclays PLC Analysts Give Cardinal Health Inc. (CAH) a $88.00 Price Target
Cardinal Health Inc. (NYSE:CAH) has been given a $88.00 target price by Barclays PLC in a research report issued to clients and investors on Monday. The brokerage currently has a a “buy” rating on the stock. Barclays PLC’s target price would indicate a potential upside of 21.63% from the stock’s current price.
Several other equities research analysts have also recently issued reports on CAH. Citigroup Inc. boosted their price target on Cardinal Health from $87.00 to $93.00 and gave the company a “neutral” rating in a research note on Wednesday, August 3rd. Leerink Swann reiterated a “buy” rating on shares of Cardinal Health in a research note on Wednesday, August 3rd. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a research note on Monday. Goldman Sachs Group Inc. cut Cardinal Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $90.00 to $83.00 in a research note on Friday, September 16th. Finally, Deutsche Bank AG boosted their price target on Cardinal Health from $83.00 to $89.00 and gave the company a “hold” rating in a research note on Thursday, August 4th. Ten research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $91.62.
Cardinal Health (NYSE:CAH) opened at 72.35 on Monday. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $91.23. The stock has a market capitalization of $23.16 billion, a price-to-earnings ratio of 17.51 and a beta of 0.73. The stock’s 50 day moving average is $73.51 and its 200-day moving average is $78.18.
Cardinal Health (NYSE:CAH) last posted its earnings results on Monday, October 31st. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.21 by $0.03. Cardinal Health had a return on equity of 25.20% and a net margin of 1.08%. The company had revenue of $32 billion for the quarter, compared to the consensus estimate of $31.12 billion. During the same quarter in the prior year, the business earned $1.38 earnings per share. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. On average, equities research analysts expect that Cardinal Health will post $5.47 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, January 15th. Investors of record on Tuesday, January 3rd will be issued a $0.4489 dividend. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $1.80 dividend on an annualized basis and a yield of 2.48%. Cardinal Health’s payout ratio is 43.58%.
In other Cardinal Health news, Chairman George S. Barrett sold 217,995 shares of the stock in a transaction dated Thursday, November 10th. The stock was sold at an average price of $71.29, for a total transaction of $15,540,863.55. Following the completion of the sale, the chairman now directly owns 682,226 shares in the company, valued at approximately $48,635,891.54. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Stuart G. Laws sold 9,703 shares of the stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $82.45, for a total value of $800,012.35. Following the sale, the senior vice president now owns 2,718 shares of the company’s stock, valued at $224,099.10. The disclosure for this sale can be found here. 0.94% of the stock is owned by corporate insiders.
A number of hedge funds have recently modified their holdings of CAH. Integrated Investment Consultants LLC increased its stake in shares of Cardinal Health by 15.4% in the second quarter. Integrated Investment Consultants LLC now owns 1,459 shares of the company’s stock worth $114,000 after buying an additional 195 shares during the last quarter. JFS Wealth Advisors LLC increased its stake in shares of Cardinal Health by 8,281.0% in the second quarter. JFS Wealth Advisors LLC now owns 1,760 shares of the company’s stock worth $137,000 after buying an additional 1,739 shares during the last quarter. Quadrant Capital Group LLC increased its stake in shares of Cardinal Health by 2.4% in the third quarter. Quadrant Capital Group LLC now owns 1,906 shares of the company’s stock worth $142,000 after buying an additional 44 shares during the last quarter. Advisory Services Network LLC increased its stake in shares of Cardinal Health by 398.2% in the second quarter. Advisory Services Network LLC now owns 1,948 shares of the company’s stock worth $152,000 after buying an additional 1,557 shares during the last quarter. Finally, Acrospire Investment Management LLC increased its stake in shares of Cardinal Health by 150.0% in the third quarter. Acrospire Investment Management LLC now owns 2,000 shares of the company’s stock worth $155,000 after buying an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 88.19% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.